Summary
Johnson & Johnson (JNJ) filed an 8-K on January 26, 2010, reporting its financial results for the fourth quarter ended January 3, 2010. The primary focus of this filing is the release of the company's sales and earnings data for the period. Investors can find the detailed financial performance in the attached press release and supplementary sales data. This report signals the close of the 2009 fiscal year and provides an initial look at the company's performance heading into 2010, allowing investors to assess revenue generation and profitability trends. While the 8-K itself is a procedural document, it directs investors to the substantive financial disclosures within the accompanying exhibits. These exhibits are crucial for understanding JNJ's performance, including revenue growth or decline, net earnings, and potentially segment-specific sales figures. Investors should review these materials to gauge the company's ability to maintain its market position and profitability amidst the prevailing economic conditions at the time.
Key Highlights
- 1Johnson & Johnson announced its fourth quarter and full-year 2009 financial results on January 26, 2010.
- 2The filing includes a press release detailing sales and earnings for the period ended January 3, 2010.
- 3Unaudited comparative supplementary sales data and condensed consolidated statements of earnings for the fourth quarter are provided.
- 4This report provides investors with key financial performance metrics for the latest reporting period.
- 5The filing serves as an official notification and release of quarterly financial outcomes.